In vitro evaluation of voriconazole against some clinically important fungi-Reference-Cited by-同舟云学术

In vitro evaluation of voriconazole against some clinically important fungi

Published:1997-08 Issue:8 Volume:41 Page:1832-1834
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

McGinnis M R¹,Pasarell L¹,Sutton D A¹,Fothergill A W¹,Cooper C R¹,Rinaldi M G¹

Affiliation:

1. Department of Pathology and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston 77555-0609, USA.

Abstract

Voriconazole was compared to amphotericin B, fluconazole, and itraconazole by using an in vitro macrobroth dilution test based upon current National Committee for Clinical Laboratory Standards tentative standards against the dimorphic fungi and several opportunistic molds and yeasts. In all instances, the voriconazole MICs were lower than those of fluconazole. In most instances, the MICs were lower than the recorded MICs of amphotericin B and itraconazole.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.41.8.1832

Reference26 articles.

1. Barchiesi F. M. Restrepo D. A. McGough and M. G. Rinaldi. 1995. In vitro activity of a new antifungal triazole: UK-109 496 abstr. F71 p. 125. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

2. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species;Barry A. L.;Antimicrob. Agents Chemother.,1996

3. Denning D. A. del Favero E. Gluckman D. Norfolk M. Ruhnke S. Yonren P. Troke and N. Sarantis. 1995. UK-109 496 a novel wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis abstr. F80 p. 126. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

4. Dupont B. D. Denning H. Lode S. Yonren P. Troke and N. Sarantris. 1995. UK-109 496 a novel wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in chronic invasive aspergillosis abstr. F81 p. 127. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

5. Espinel-Ingroff A. 1996. Evaluation of the in vitro activity of the new triazole voriconazole against opportunistic filamentous fungi abstr. F84 p. 114. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei;Medical Mycology;2023-11

2. Management of osteoarticular fungal infections in the setting of immunodeficiency;Expert Review of Anti-infective Therapy;2020-04-02

3. Synthesis, Anti-inflammatory, Antimicrobial Potential and Molecular Docking Studies of 4,5-Disubstituted-1,2,4-Triazole Thioacetate Derivatives;Letters in Drug Design & Discovery;2019-06-27

4. Genomewide Elucidation of Drug Resistance Mechanisms for Systemically Used Antifungal Drugs Amphotericin B, Caspofungin, and Voriconazole in the Budding Yeast;Antimicrobial Agents and Chemotherapy;2019-06-17

5. Scedosporium apiospermum: A Rare Cause of Aggressive Orbital Apex Syndrome;Cureus;2018-12-17